Welcome to LookChem.com Sign In|Join Free

CAS

  • or

155-97-5

Post Buying Request

155-97-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

155-97-5 Usage

Uses

Cholinergic.

Check Digit Verification of cas no

The CAS Registry Mumber 155-97-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,5 and 5 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 155-97:
(5*1)+(4*5)+(3*5)+(2*9)+(1*7)=65
65 % 10 = 5
So 155-97-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1

155-97-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate

1.2 Other means of identification

Product number -
Other names Pyridostigmin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:155-97-5 SDS

155-97-5Upstream product

155-97-5Downstream Products

155-97-5Related news

Myasthenia gravis requiring PYRIDOSTIGMINE (cas 155-97-5) treatment in a national population cohort09/30/2019

Background:  Pyridostigmine is the first drug of choice for patients with myasthenia gravis (MG). The drug is not prescribed regularly to any other patient groups. We aimed to determine the prevalence, incidence and gender‐specific characteristics of patients with MG needing drug treatment in a...detailed

Effets neuromusculaires de la PYRIDOSTIGMINE (cas 155-97-5) sur des cultures organotypiques de moelle epiniere et de muscle09/29/2019

Pyridostigmine bromide (PB) promotes and then silences cholinergic muscle activity, and disrupts the junctional regions of muscle fibers and associated nerve terminals, in organotypic mouse spinal cord-muscle cultures continuously treated with low concentrations of the drug for up to 14 days. S...detailed

A comparison of the efficacy of PYRIDOSTIGMINE (cas 155-97-5) alone and the combination of PYRIDOSTIGMINE (cas 155-97-5) with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice09/28/2019

The ability of two types of pharmacological pretreatment (pyridostigmine alone or pyridostigmine in combination with two anticholinergic drugs) to increase the resistance of rats and mice against tabun and to increase the therapeutic efficacy of common antidotal treatment of tabun-poisoned rats ...detailed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 155-97-5